517 related articles for article (PubMed ID: 11421501)
1. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease.
Kasielski M; Nowak D
Respir Med; 2001 Jun; 95(6):448-56. PubMed ID: 11421501
[TBL] [Abstract][Full Text] [Related]
2. Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking.
Nowak D; Kasielski M; Antczak A; Pietras T; Bialasiewicz P
Respir Med; 1999 Jun; 93(6):389-96. PubMed ID: 10464820
[TBL] [Abstract][Full Text] [Related]
3. Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease?
Koechlin C; Couillard A; Simar D; Cristol JP; Bellet H; Hayot M; Prefaut C
Am J Respir Crit Care Med; 2004 May; 169(9):1022-7. PubMed ID: 15001462
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of oxidative stress markers in exhaled breath condensate and in serum of patients with tuberculosis and sarcoidosis].
Kwiatkowska S; Luczyńska M; Grzelewska-Rzymowska I; Nowak D; Zieba M
Pol Merkur Lekarski; 2005 Jul; 19(109):37-40. PubMed ID: 16194024
[TBL] [Abstract][Full Text] [Related]
5. [The monitoring and its clinical significance of the hydrogen peroxide and interleukin-6 levels in exhaled breath condensate of chronic obstructive pulmonary diseases patients undergoing mechanical ventilation].
Yang GH; Wang GF
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Aug; 22(8):455-8. PubMed ID: 20804645
[TBL] [Abstract][Full Text] [Related]
6. Increased hydrogen peroxide concentration in the exhaled breath condensate of stable COPD patients after nebulized N-acetylcysteine.
Rysz J; Stolarek RA; Luczynski R; Sarniak A; Wlodarczyk A; Kasielski M; Nowak D
Pulm Pharmacol Ther; 2007; 20(3):281-9. PubMed ID: 16753318
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of ferulic acid on nicotine-induced DNA damage and cellular changes in cultured rat peripheral blood lymphocytes: a comparison with N-acetylcysteine.
Sudheer AR; Muthukumaran S; Kalpana C; Srinivasan M; Menon VP
Toxicol In Vitro; 2007 Jun; 21(4):576-85. PubMed ID: 17222527
[TBL] [Abstract][Full Text] [Related]
8. Long-term oral n-acetylcysteine reduces exhaled hydrogen peroxide in stable COPD.
De Benedetto F; Aceto A; Dragani B; Spacone A; Formisano S; Pela R; Donner CF; Sanguinetti CM
Pulm Pharmacol Ther; 2005; 18(1):41-7. PubMed ID: 15607126
[TBL] [Abstract][Full Text] [Related]
9. The effect of different treatment modalities on oxidative stress in COPD.
Kuleci S; Hanta I; Kocabas A; Canacankatan N
Adv Ther; 2008 Jul; 25(7):710-7. PubMed ID: 18592146
[TBL] [Abstract][Full Text] [Related]
10. Cigarette smoking does not increase hydrogen peroxide levels in expired breath condensate of patients with stable COPD.
Nowak D; Kasielski M; Pietras T; Białasiewicz P; Antczak A
Monaldi Arch Chest Dis; 1998 Jun; 53(3):268-73. PubMed ID: 9785809
[TBL] [Abstract][Full Text] [Related]
11. Ellagic acid, a natural polyphenol protects rat peripheral blood lymphocytes against nicotine-induced cellular and DNA damage in vitro: with the comparison of N-acetylcysteine.
Sudheer AR; Muthukumaran S; Devipriya N; Menon VP
Toxicology; 2007 Jan; 230(1):11-21. PubMed ID: 17188416
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress.
Swarnalatha G; Ram R; Neela P; Naidu MU; Dakshina Murty KV
Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):852-8. PubMed ID: 20814119
[TBL] [Abstract][Full Text] [Related]
13. [N-acetylcysteine: a functional oxygen radical scavenger in vitro and ex vivo in monocytes and neutrophilic granulocytes of patients with COPD].
Jaworska M; Gillissen A; Schärling B; Wickenburg D; Schultze-Werninghaus G
Pneumologie; 1995 Oct; 49(10):539-45. PubMed ID: 8584524
[TBL] [Abstract][Full Text] [Related]
14. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease.
Dekhuijzen PN; Aben KK; Dekker I; Aarts LP; Wielders PL; van Herwaarden CL; Bast A
Am J Respir Crit Care Med; 1996 Sep; 154(3 Pt 1):813-6. PubMed ID: 8810624
[TBL] [Abstract][Full Text] [Related]
15. Effect of inhaled N-acetylcysteine on hydrogen peroxide exhalation in healthy subjects.
Szkudlarek U; Zdziechowski A; Witkowski K; Kasielski M; Luczyńska M; Luczyński R; Sarniak A; Nowak D
Pulm Pharmacol Ther; 2004; 17(3):155-62. PubMed ID: 15123225
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials.
Grandjean EM; Berthet P; Ruffmann R; Leuenberger P
Clin Ther; 2000 Feb; 22(2):209-21. PubMed ID: 10743980
[TBL] [Abstract][Full Text] [Related]
17. [Antioxidant treatment with N-acetylcysteine and vitamin C in patients with chronic bronchitis].
Lukas R; Schärling B; Schultze-Werninghaus G; Gillissen A
Dtsch Med Wochenschr; 2005 Mar; 130(11):563-7. PubMed ID: 15761783
[TBL] [Abstract][Full Text] [Related]
18. Inhaled glucocorticosteroids decrease hydrogen peroxide level in expired air condensate in asthmatic patients.
Antczak A; Kurmanowska Z; Kasielski M; Nowak D
Respir Med; 2000 May; 94(5):416-21. PubMed ID: 10868702
[TBL] [Abstract][Full Text] [Related]
19. The effect of N-acetylcysteine on pulmonary lipid peroxidation and tissue damage.
Akca T; Canbaz H; Tataroglu C; Caglikulekci M; Tamer L; Colak T; Kanik A; Bilgin O; Aydin S
J Surg Res; 2005 Nov; 129(1):38-45. PubMed ID: 16243047
[TBL] [Abstract][Full Text] [Related]
20. Erdosteine enhances airway response to salbutamol in patients with mild-to-moderate COPD.
Dal Negro R; Visconti M; Trevisan F; Bertacco S; Micheletto C; Tognella S
Ther Adv Respir Dis; 2008 Oct; 2(5):271-7. PubMed ID: 19124377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
